Valuation: Highnoon Laboratories Limited

Market Cap 48.77B 176M 158M 145M 132M 246M 16.75B 251M 1.73B 696M 8.81B 662M 648M 27.78B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 48.77B 176M 158M 145M 132M 246M 16.75B 251M 1.73B 696M 8.81B 662M 648M 27.78B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.43x
Free-Float
50.02%
Yield 2026 *
4.89%
Yield 2027 * 5.65%
1 day-0.05%
1 week-0.02%
1 month-1.34%
3 months-6.40%
6 months+0.77%
Current year-9.97%
1 week 915
Extreme 915
938
1 month 910
Extreme 910
980
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,168.97
3 years 416.5
Extreme 416.5
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 01/04/2015
Chief Executive Officer 63 01/01/1996
Director of Finance/CFO - 01/04/2020
Director TitleAgeSince
Chairman - 07/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%-0.02% - - 176M
Average -0.05%
Weighted average by Cap. -0.05%

Financials

2026 *2027 *
Net sales 30.4B 110M 98.45M 90.56M 82.05M 153M 10.44B 156M 1.08B 434M 5.49B 413M 404M 17.31B 34.16B 124M 111M 102M 92.21M 172M 11.73B 176M 1.21B 487M 6.17B 464M 454M 19.46B
Net income - -
Net Debt - -
Projected Income Statement - Annual - Highnoon Laboratories Limited
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
30/10/26 PKR 920.51 -0.05% 2,503
29/10/26 PKR 921.01 +0.24% 14,527
28/10/26 PKR 918.83 -0.26% 13,483
27/10/26 PKR 921.26 -0.33% 9,359
26/10/26 PKR 924.29 +0.40% 9,394
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
920.51PKR
Average target price
1,121.00PKR
Spread / Average Target
+21.78%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Highnoon Laboratories Limited
  1. Stock Market
  2. Stocks
  3. HINOON Stock